Company profile: Immunophotonics
1.1 - Company Overview
Company description
- Provider of immunotherapy-based cancer treatments, including IP-001, a proprietary glycan polymer that stimulates immune responses against cancer and infectious diseases by acting as an antigen depot and immune activator; and an Abscopalizing Technique involving IP-001 injection with tumor ablation or radiation to induce a systemic immune response against cancer.
Products and services
- Abscopalizing Technique: An adjunctive method that injects IP-001 alongside tumor ablation or radiation to induce a systemic immune response against cancer, integrating local procedures with immunologic activation
- Immunotherapy-based Treatments for Cancer: The company engineers therapies that stimulate anti-cancer immune responses by employing IP-001’s antigen depot and immune activator properties within treatment regimens
- IP-001: A proprietary glycan polymer that acts as an antigen depot and immune activator, engineered to stimulate immune responses against cancer and infectious diseases in targeted therapeutic applications
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Immunophotonics
Telo Genomics
HQ: Canada
Website
- Description: Provider of telomere-based platforms for biopsies and related technologies in oncology and neurological diseases. Offerings include TeloView, which quantifies genomic instability by measuring the 3D structure and spatial organization of telomeres to assess disease aggressiveness and treatment response, and TeloView SMM, a molecular assay identifying high-risk Smouldering Multiple Myeloma patients for treatment intervention decisions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Telo Genomics company profile →
Agilent
HQ: United States
Website
- Description: Provider of scientific and laboratory management solutions for analytical scientists and clinical researchers, offering instruments, software, and HPLC, GC & spectroscopy supplies for chemical analysis; life sciences tools for genomics, proteomics, and cell analysis; diagnostic solutions including pathology and molecular diagnostics; and products such as 8850 GC and NovoCyte Opteon.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Agilent company profile →
StemoniX
HQ: United States
Website
- Description: Provider of stem cell–based, human-relevant in vitro platforms for drug discovery and toxicity testing. Products include NerveSim (3D peripheral nervous system model with nerve conduction and neurodegeneration metrics), BrainSim (3D brain organoid platform), and microBrain (human iPSC-derived CNS screening with functional cortical neuron–astrocyte networks). Founded in 2014, headquartered in Maple Grove, Minnesota.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full StemoniX company profile →
Incept Biosystems
HQ: United States
Website
- Description: Provider of innovative microscale technologies that provide fertility specialists breakthrough capabilities to treat infertility, improving the in vitro manipulation, performance, and viability of high-value cells, with a mission to set the standard for next-generation clinical devices for Assisted Reproductive.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Incept Biosystems company profile →
LEAP Technologies
HQ: Australia
Website
- Description: Provider of micro dispensing, PAL accessories, support, and repair services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full LEAP Technologies company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Immunophotonics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Immunophotonics
2.2 - Growth funds investing in similar companies to Immunophotonics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Immunophotonics
4.2 - Public trading comparable groups for Immunophotonics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →